Low-Dosage Apatinib in Treating Advanced Pulmonary Adenocarcinoma With Kras Mutation After Osimertinib Resistance: A Case Report

No abstract available
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Letters to the Editor Source Type: research